CCL2, a key monocyte/macrophage chemoattractant22, and CCL3, a macrophage, polymorphonuclear cell, B and CD8 T lymphocyte chemoattractant23, have been most studied and serum and plasma levels of these chemokines are increased in patients with epilepsy compared to healthy or non-epileptic controls24,25. Here, CCL2 is linked to epilepsy.